Skip to content

Skip to secondary menu

Jehovah’s Witnesses


Hematology (Autoimmune Diseases and Conditions)

Other Cytopenias

Thrombopoietin-receptor agonists in haematological disorders: the Danish experience.

Gudbrandsdottir S, Frederiksen H, Hasselbalch H.

Source‎: Platelets 2012;23(6):423-9.

Indexed‎: PubMed 22185370

DOI‎: 10.3109/09537104.2011.634931

Successful treatment of autoimmune neutropenia with recombinant human granulocyte-colony stimulating factor (R-metHuG-CSF).

Krishnan K, Ross CW, Bockenstedt PL, Adams PT.

Source‎: Clin Lab Haematol 1997;19(2):105-9.

Indexed‎: PubMed 9218149

The use of rhG-CSF in chronic autoimmune neutropenia: reversal of autoimmune phenomena, a case history.

Kuijpers TW, de Haas M, de Groot CJ, von dem Borne AE, Weening RS.

Source‎: Br J Haematol 1996;94(3):464-9.

Indexed‎: PubMed 8790143

B-cell depletion for autoimmune thrombocytopenia and autoimmune hemolytic anemia in pediatric systemic lupus erythematosus.

Kumar S, Benseler SM, Kirby-Allen M, Silverman ED.

Source‎: Pediatrics 2009;123(1):e159-63.

Indexed‎: PubMed 19074962

DOI‎: 10.1542/peds.2008-2361

Successful treatment of refractory immune thrombocytopenia with anti-CD20 antibody in a patient with systemic lupus erythematosus.

Lee JW, Kim HA, Sung JM, Suh CH.

Source‎: Lupus 2010;19(2):227-8.

Indexed‎: PubMed 19884220

DOI‎: 10.1177/0961203309345723

Danazol in the treatment of systemic lupus erythematosus: a qualitative systematic review.

Letchumanan P, Thumboo J.

Source‎: Semin Arthritis Rheum 2011;40(4):298-306.

Indexed‎: PubMed 20541792

DOI‎: 10.1016/j.semarthrit.2010.03.005

Thrombotic thrombocytopenic purpura treated with vincristine in a Jehovah's Witness.

Walia SS, Walia MS, Walia HS.

Source‎: Asian J Transfus Sci 2011;5(2):180-1.

Indexed‎: PubMed 21897605

DOI‎: 10.4103/0973-6247.83255

The medical section of is designed as an informational resource primarily for use by clinicians and other health-care professionals. It provides neither medical advice nor treatment recommendations and does not substitute for an appropriately qualified health-care provider. The clinical literature cited is not published by Jehovah’s Witnesses, but it outlines transfusion-alternative strategies that might be considered. It is the responsibility of each qualified health-care provider to maintain awareness of new information, discuss options for care, and assist patients in making choices in accord with their medical condition, wishes, values, and beliefs. Not all listed strategies are appropriate or acceptable to all patients.

Patients: Always seek the advice of your doctor or other qualified health-care provider regarding medical conditions or treatments. Check with a doctor if you suspect you are ill.

The use of this website is governed by its terms of use.